These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26395593)

  • 21. New safety signals assessed by the Pharmacovigilance Risk Assessment Committee at EU level in 2014-2017.
    Farcaş A; Măhălean A; Bulik NB; Leucuta D; Mogoșan C
    Expert Rev Clin Pharmacol; 2018 Oct; 11(10):1045-1051. PubMed ID: 30269618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future.
    Fabiano V; Mameli C; Zuccotti GV
    Expert Opin Drug Saf; 2012 Jan; 11(1):95-105. PubMed ID: 21548838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of the National pharmacovigilance system in Malta - implementing and operating a pharmacovigilance management system.
    Tanti A; Micallef B; Serracino-Inglott A; Borg JJ
    Expert Opin Drug Saf; 2017 Jan; 16(1):65-76. PubMed ID: 27732110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR.
    Pierce CE; de Vries ST; Bodin-Parssinen S; Härmark L; Tregunno P; Lewis DJ; Maskell S; Van Eemeren R; Ptaszynska-Neophytou A; Newbould V; Dasgupta N; Wisniewski AFZ; Gama S; Mol PGM
    Drug Saf; 2019 Apr; 42(4):477-489. PubMed ID: 30911975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adverse drug effects in the community pharmacy].
    Arnet I; Seidling HM; Hersberger KE
    Ther Umsch; 2015 Dec; 72(11-12):687-92. PubMed ID: 26654812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 9th Biennial Conference on Signal Detection and Interpretation in Pharmacovigilance.
    Osborne V; Shakir SAW
    Drug Saf; 2018 Jan; 41(1):139-141. PubMed ID: 28795368
    [No Abstract]   [Full Text] [Related]  

  • 27. [Direct reporting by patients of adverse drug reactions in Spain].
    Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G
    Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nurses must report adverse drug reactions.
    Griffith R
    Br J Nurs; 2013 Apr 25-May 8; 22(8):484-5. PubMed ID: 23905231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicine Safety Monitoring in Pediatric Population in India.
    Kaur I; Kalaiselvan V; Singh GN
    Indian J Pediatr; 2016 May; 83(5):479-80. PubMed ID: 26634262
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacovigilance in pregnancy: adverse drug reactions associated with fetal disorders.
    Wettach C; Thomann J; Lambrigger-Steiner C; Buclin T; Desmeules J; von Mandach U
    J Perinat Med; 2013 May; 41(3):301-7. PubMed ID: 23027583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving pharmacovigilance in Europe.
    Moore N; Bégaud B
    BMJ; 2010 Apr; 340():c1694. PubMed ID: 20385717
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacovigilance in Russia: current state of affairs, challenges, and prospects.
    Gildeeva G; Belostotsky A
    Curr Med Res Opin; 2017 Dec; 33(12):2161-2166. PubMed ID: 28562116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacovigilance in pharmacy practice].
    Duquet N
    J Pharm Belg; 2011 Dec; (4):97-103. PubMed ID: 22299235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety warning: combination products containing codeine and ibuprofen.
    Drug Ther Bull; 2023 Feb; 61(2):19. PubMed ID: 36564156
    [No Abstract]   [Full Text] [Related]  

  • 35. Towards on-line ADR detection: an innovative data cube-based approach.
    Lin WY; Du JW
    Stud Health Technol Inform; 2013; 192():1218. PubMed ID: 23920992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 150 years of pharmacovigilance.
    Routledge P
    Lancet; 1998 Apr; 351(9110):1200-1. PubMed ID: 9643710
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacovigilance: urgent need in midwestern region of Nepal.
    Khanal S; Gyawali S; Kanodia R; Rathor RS
    Kathmandu Univ Med J (KUMJ); 2009; 7(28):470. PubMed ID: 20502096
    [No Abstract]   [Full Text] [Related]  

  • 38. [Understanding and reducing the risk of adverse drug reactions in pediatric patients].
    Gotta V; van den Anker J; Pfister M
    Ther Umsch; 2015 Dec; 72(11-12):679-86. PubMed ID: 26654811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Safety of medicinal products and reporting of adverse drug reactions].
    Skibicka I; Maciejczyk A
    Neurol Neurochir Pol; 2004; 38(6):503-10. PubMed ID: 15654675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aims and approaches of Web-RADR: a consortium ensuring reliable ADR reporting via mobile devices and new insights from social media.
    Ghosh R; Lewis D
    Expert Opin Drug Saf; 2015; 14(12):1845-53. PubMed ID: 26436834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.